Are there any benefits of Betoptic® S (betaxolol HCl ophthalmic suspension) over other β-blockers in the treatment of glaucoma?

Author： Yarangümeli Alper   Kural Gülcan  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.5, 2004-05, pp. : 1071-1081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for perioperative β-blockers questioned

By  

Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

The primacy of β-blockers for hypertension is challenged

By  

Inpharma, Vol. 1, Iss. 1565, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

UK NICE advise a block on β-blockers

By  

Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Evidence lacking for benefit of perioperative β-blockers and statins

By  

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

β-blockers underprescribed, inadequately dosed in AMI, HF

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite